The Food and Drug Administration has approved Colorado's plan to import certain prescription drugs from Canada, marking a significant step in the state's effort to reduce medication prices for its residents. The decision, announced Monday, allows the state to move forward with a program that has been in development for years.
Colorado becomes the first state to receive federal approval for such a drug importation plan under a 2020 rule change aimed at lowering costs. The program targets high-price medications, though specific drugs were not immediately detailed by regulators. The move could serve as a model for other states exploring similar approaches.
Under the approved plan, Colorado will oversee the importation of drugs that are FDA-approved and manufactured in Canada, ensuring safety standards are met. The state estimates the program could save residents millions annually, though exact figures were not provided in the announcement. Implementation is expected to take months as logistical details are finalized.
The pharmaceutical industry has long opposed importation schemes, arguing they risk introducing counterfeit or unsafe medications into the supply chain. Critics also contend that savings may be limited, as Canadian suppliers may not have the capacity to meet U.S. demand. The plan faces potential legal challenges from drugmakers.